Feed BOSOX
BO

Boston Trust Walden Small Cap Fund BOSOX · NASDAQ

$18.46 -0.75% (-$0.14)

Summary

51 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 28% a year over the last 3 years.
  • It has raised its dividend 5 years in a row.

What to watch

  • The company made a loss over the last 12 months.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

Revenue grew by 28% a year over the last 3 years.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

Moderate, at risk
Yield
3.96%
Raised in a row
5 years

You receive $0.73 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.